Objective-To investigate whether exposure of human monocytes/macrophages to tobacco smoke induces their release of membrane microvesicles (MVs) that carry tissue factor (TF) released from cells, whether smoke-induced MVs are procoagulant, and what cellular processes might be responsible for their production. Methods and Results-We found that exposure of human THP-1 monocytes and primary human monocyte-derived macrophages to 3.75% tobacco smoke extract (TSE) significantly increased their total and TF-positive MV generation. More importantly, MVs released from TSE-treated human monocytes/macrophages exhibited 3 to 4 times the procoagulant activity of control MVs, as assessed by TF-dependent generation of factor Xa. Exposure to TSE increased TF mRNA and protein expression and cell surface TF display by both THP-1 monocytes and primary human monocyte-derived macrophages. In addition, TSE exposure caused activation of C-Jun-N-terminal kinase (JNK), p38, extracellular signal regulated kinase (ERK) mitogen-activated protein kinases (MAPK), and apoptosis (a major mechanism for MV generation). Treatment of THP-1 cells with inhibitors of ERK, MAP kinase kinase (MEK), Ras, or caspase 3, but not p38 or JNK, significantly blunted TSE-induced apoptosis and MV generation. Surprisingly, neither ERK nor caspase 3 inhibition altered the induction of cell surface TF display by TSE, indicating an effect solely on MV release. Inhibition of ERK or caspase 3 essentially abolished TSE-induced generation of procoagulant MVs from THP-1 monocytes. Conclusion-Tobacco smoke exposure of human monocytes/macrophages induces cell surface TF display, apoptosis, and ERK-and caspase 3-dependent generation of biologically active procoagulant MVs. These processes may be novel contributors to the pathological hypercoagulability of active and secondhand smokers. (Arterioscler Thromb Vasc Biol.
s of 2002, an estimated 1.3 billion people in the world actively smoked cigarettes, and even more individuals are exposed to secondhand tobacco smoke. 1, 2 Tobacco smoke substantially increases the risk of atherothrombotic disease in coronary, cerebral, and peripheral arteries 1, [3] [4] [5] [6] [7] [8] ; and of venous thrombosis. 9 -11 Public smoking bans are associated with rapid and significant reductions in atherothrombotic cardiovascular events, 3, 12 and this beneficial effect promptly disappeared in 1 municipality when it lifted its ban. 13 Moreover, much of the decline in cardiovascular events in America and Europe during the past 2 to 3 decades has been attributed to management of the major conventional cardiovascular risk factors, including reductions in cigarette smoking. 12, 14, 15 Despite its wide importance, the underlying pathological mechanisms for cardiovascular harm from tobacco smoke remain poorly understood. 3 Herein, we focused on microvesicles (MVs), also called microparticles, which are released from the plasma membrane during cell activation or apoptosis and have played an important role in thrombus formation. 16 -20 MVs transport tissue factor (TF), a transmembrane molecule that initiates coagulation in vivo. 16 -20 Several studies have shown that cigarette smoking increases TF expression on peripheral monocytes, 21 by cultured mouse alveolar macrophages, 22 and in atherosclerotic lesions. 23 Smokers have higher plasma concentrations of TF than do nonsmokers, and smoking just 2 cigarettes in a row increases their TF levels even further. 24 Nevertheless, we are aware of no prior reports characterizing cellular mechanisms for increased plasma TF in smokers. In the current study, we sought to determine whether exposure of human monocytes/ macrophages to tobacco smoke induces the release of MVs, whether these smoke-induced MVs are procoagulant, and what cellular processes might be responsible for their production.
Methods
The human THP-1 monocytic cell line (ATCC, Manassas, Va) was maintained in RPMI medium 1640 with 10% FBS. Primary human monocyte-derived macrophages (hMDMs) were prepared from fresh buffy coats by selecting monocytes by adherence followed by differentiation into macrophages. 20 Tobacco smoke extract (TSE) was prepared as previously described. 25, 26 At the beginning of each experiment, THP-1 monocytes or hMDMs were transferred to serum-free RPMI medium 1640 plus BSA supplemented with different concentrations of TSE, ranging from 0% (control) to 3.75% (vol/vol), and then incubated at 37°C for 2 to 20 hours (0 hours denotes harvest immediately before adding TSE). In time-course studies of kinase activation, cells were placed into serum-free medium simultaneously; TSE was added at different times; and all cells were harvested simultaneously. In experiments using kinase or caspase 3 inhibitors, the compounds were added to cells 1 hour before the addition of TSE and remained until the end of the experiment, at concentrations as follows: SP600125, 10 mol/L; SB202190, 10 mol/L; U0126, 10 mol/L; PD98059, 20 mol/L; farnesyl transferase inhibitor (FTI), 20 mol/L; and caspase 3 inhibitor Z-DEVD-FMK, 100 mol/L. Flow cytometric characterization of MVs and cells was performed according to previously published protocols. 20 Additional experimental details are provided in the supplemental materials (available online at http://atvb.ahajournals.org).
Results
We found that exposure of human THP-1 monocytes to TSE significantly increased total MV release, in a dose-( Figure  1A ) and a time-dependent manner (supplemental Figure I) . Smoke-induced MV release was confirmed by 2 independent assay methods ( Figure 1A and C) . Likewise, TSE significantly stimulated total MV generation from primary hMDMs ( Figure 1B and D) . In addition, the numbers of TF-positive MVs released from TSE-treated human THP-1 cells ( Figure  1E ) and hMDMs ( Figure 1F ) were significantly higher than those from control cells incubated without TSE. More importantly, we found that TSE treatment of THP-1 cells ( Figure  1G ) or hMDMs ( Figure 1H ) for 20 hours tripled the procoagulant activity of their MVs.
Because MVs are released from the plasma membrane, we examined whether tobacco smoke affects expression and cell surface display of TF on human THP-1 monocytes and hMDMs. We found that exposure to 3.75% TSE for 2 hours increased TF mRNA levels in both THP-1 cells (Figure 2A cates not significant. In B through H, the displayed probability values were computed using the t test.
TSE for 6 hours substantially increased their content of TF protein ( Figure 2C and D) and stimulated cell surface TF display ( Figure 2E and F). In a time course, display of TF on the surface of THP-1 cells peaked at 6 hours after the addition of TSE and was still elevated at 20 hours, compared with baseline (supplemental Figure II) . The decline in cell-surface TF from 6 to 20 hours may reflect, in part, the release of cellular TF into the medium on MVs. Tobacco smoke has been reported to activate a number of intracellular signaling pathways, [27] [28] [29] [30] [31] [32] [33] but their roles in smokeinduced MV generation are unknown. Consistent with prior literature in other cell types, 27, 34, 35 we found that exposure of THP-1 monocytes to TSE increased the phosphorylation of 3 major mitogen-activated protein (MAP) kinases (ie, c-Jun-Nterminal kinase [JNK], p38, and extracellular signal regulated kinase [ERK]) ( Figure 3 ). The time courses differed considerably. Phosphorylated JNK was increased at 0.5 hours but returned to nearly its baseline level after 1 to 6 hours of TSE exposure ( Figure 3A) . In contrast, phosphorylated p38 and phosphorylated ERK were partially induced at 0.5 hours and peaked at 2 to 4 hours; the increase lasted throughout the entire 6-hour period of TSE exposure ( Figure 3B and C) . Then, we sought to determine which, if any, of these activated MAP kinases might be involved in TSE-induced generation of biologically active MVs. Inhibitors of ERK or its upstream molecules (ie, MEK and Ras) significantly decreased total MV generation from TSE-exposed THP-1 cells, in some cases to levels statistically indistinguishable from control, as measured by flow cytometry (supplemental Figure III) or ELISA ( Figure   Figure 2 . Exposure of human monocytes/macrophages to TSE induces TF mRNA, protein, and cell surface display. A and B, Levels of TF mRNA, measured by quantitative RT-PCR in THP-1 cells (A) and hMDMs (B) after a 2-hour exposure to control medium or 3.75% TSE. C and D, Quantifications and representative immunoblots of total TF content of THP-1 cells (C) and hMDMs (D) after a 6-hour exposure to control medium or 3.75% TSE, as indicated. E and F, Flow cytometric histograms of cell surface TF display by THP-1 cells (E) and hMDMs (F) after a 6-hour incubation in control media (dashed lines) or 3.75% TSE (heavy black lines). Cells that were treated with 3.75% TSE for 6 hours but stained with an isotype control antibody are shown as thin black lines (E and F). The experiments in each of the panels were repeated at least 3 times, and the column graphs display meanϮSEM (A, C, and D) or medians in box-andwhisker plots (B). In A, C, and D, the displayed probability values were computed using the t test. The Mann-Whitney ranksum test was used for B. FITC indicates fluorescein isothiocyanate. . Surprisingly, treatment of THP-1 cells with the ERK inhibitor did not significantly affect TSE-induced display of TF on the cell surface (supplemental Figure IV) ; however, ERK inhibition decreased TSE-induced generation of TF-positive MVs to a level indistinguishable from control, implying an effect solely on MV release ( Figure 4B ). Most important, ERK inhibition essentially blocked the ability of TSE to stimulate the release of procoagulant MVs from THP-1 monocytes ( Figure 4C and D) . Thus, TSE activates the ERK MAP kinase pathway, and this activation is crucial for the generation of procoagulant MVs.
Next, we examined the role of programmed cell death in the production of procoagulant MVs after TSE exposure. Consistent with prior literature 36 -39 in other cell types, TSE exposure of THP-1 monocytes caused cell surface exposure of phosphatidylserine (supplemental Figure VA and B) and dose-dependent DNA fragmentation detected by TUNEL staining ( Figure 5A and B) . Likewise, exposure of human primary hMDMs to 3.75% TSE also substantially increased apoptosis, as determined by TUNEL staining (supplemental Figure VC and D) . The inhibition of ERK, MEK, or Ras, but not JNK or p38, partially decreased TSE-induced apoptosis, as assessed by TUNEL staining ( Figure 5C and D); none of these inhibitors affected TUNEL staining of THP-1 cells in the absence of TSE (data not shown). Finally, the caspase 3 inhibitor, Z-DEVD-FMK, substantially inhibited TSE-induced apoptosis ( Figure 6A and B) and decreased TSE-induced generation of total MVs, measured by flow cytometry ( Figure 6C ) and MV-ELISA ( Figure 6D ). Z-DEVD-FMK, like the ERK inhibitor, did not affect TSE-induced TF display on the cell surface (data not shown) but decreased TSE-induced procoagulant activity of the purified MVs released from THP-1 cells essentially to baseline ( Figure 6E) .
Discussion
Our results demonstrate that exposure of human monocytes and primary human macrophages to tobacco smoke provokes the generation of highly procoagulant membrane MVs, in a process requiring ERK activation and apoptosis. These cellular mechanisms may contribute to the link, in clinical and population studies, between tobacco smoke exposure (both active and secondhand) and a high risk of thrombotic events. 3,21,23,24,40 -42 Our results may also help explain why short-term cigarette smoking increases plasma TF concentrations in current smokers and why active smokers have higher levels of circulating TF than nonsmokers. 24 Consistent with this model, exposure of healthy nonsmokers to secondhand smoke was recently reported to increase circulating concentrations of MVs, although their potential prothrombotic effects were not evaluated. 43 Additional studies 36 -39 reported that exposure of experimental animals to tobacco smoke induces apoptosis of several different cell types, which we infer should increase their production of MVs. Thus, our findings are likely to be relevant in vivo.
Regarding intracellular signaling pathways, we found that TSE exposure caused transient activation of JNK and sustained activation of p38 and ERK (Figure 3 ), but only ERK appeared to be involved in TSE-induced apoptosis and MV generation. ERK MAP kinases are known for their involvement in cell survival, but recent evidence suggests that ERK activation can also contribute to cell death under certain conditions. 44, 45 For example, the Ras/MEK/ERK pathway was reported to play a key role in apoptosis induced by UV-A irradiation 46 or a calcium ionophore. 44 Based on our results, TSE induces TF expression and cell surface display ( Figure   2 ) through a process independent of ERK or caspase 3. In other circumstances, TF expression is either regulated 47, 48 or not regulated 49 through ERK activation. Then, our TSEexposed cells underwent apoptosis and extensive apoptotic vesiculation, which depends on ERK and caspase 3 and leads to the release of biologically active TF on highly procoagulant MVs (Figures 1, 4, and 6 ). In addition, the presence of phosphatidylserine on the MV surface is a key identifying characteristic during flow cytometry and ELISA analyses, and this unique surface phospholipid promotes the catalytic efficiency of complexes in the blood coagulation cascade, 19, 20, 50 especially for apoptotic MVs. 20, [51] [52] [53] The relative importance of TSE-induced TF released on MVs or remaining on cells may depend on the context. For example, biologically active TF transported by monocytederived MVs can become targeted into developing thrombi via the interaction of P-selectin glycoprotein ligand-1 (PSGL1) on the MV surface, with P-selectin displayed by newly activated platelets. 17 In contrast, the direct recruitment of intact monocytes or macrophages into early experimental clots appears to be minimal. 54, 55 In a pathophysiologic setting, atherosclerotic plaques contain MV-associated TF 56 and cellassociated TF, 23, 57 both of which we presume would increase in smokers 23, 24 and thereby contribute to thrombus formation and acute vessel occlusion on plaque rupture.
Overall, our findings indicate that exposure of human monocytes/macrophages to tobacco smoke induces cell surface TF display, apoptosis, and ERK-, and caspase 3-dependent generation of biologically active procoagulant MVs. These processes may be novel contributors to pathological hypercoagulability caused by active and secondhand exposure to tobacco smoke.
